Headache Relief in Gahanna, OH
If you suffer from chronic migraines or headaches, Botox for headache therapy may help to improve headache symptoms, providing a better quality of life. As a migraine sufferer, pain can be so intolerable, it greatly affects almost everything in your life, including work, leisure time and your family. Botox treatments can be very effective in reducing pain and symptoms that go along with migraines and headaches. Call today to speak with one of our patient coordinators to see if Botox may be right for you.
Botox for Headache Therapy – Is it Safe?
On October 15, 2010, Botox (known as Onabotulinumtoxin A) received FDA approval for treatment of chronic migraines. Botox is injected into the head and neck to treat migraines or chronic headaches. FDA approval followed evidence presented from studies funded by Allergan, Inc, which showed that migraine sufferers had improvement in symptoms after Botox applications. Since that time, randomized control trials have shown botulinum toxin type A to improve headache symptoms and quality of life when used prophylactally for patients with chronic migraine who exhibit headache characteristics.
Juvéderm, is an injectable facial filler, used by cosmetic, dermatological, and plastic surgeons. Juvéderm is used to smooth and soften deep folds and reduce facial wrinkles. Similar to cosmetic Botox, Juvéderm is a great way to look and feel younger, temporarily decreasing or eliminating lines and wrinkles. If you have lines or are worried about them forming, this can be a very effective, safe treatment.
Is Juvéderm Filler safe?
Before being released onto the U.S. market, Juvéderm was compared with Zyplast dermal filler, a bovine-based injectable facial filler made from collagen. In clinical studies conducted at several U.S. medical centers to evaluate safety and efficacy, or effectiveness, 146 subjects were followed for 24 weeks. The subjects had Juvéderm injected into one nasolabial fold and Zyplast in the other. Using scientific measuring scales, Juvéderm was deemed to provide a more persistent correction in the subjects’ facial folds. At the end of the study, the researchers asked subjects to judge which fold looked better to them. Eighty-eight percent chose the area treated with Juvéderm. Before FDA approval, two other clinical studies on Juvéderm were done on a total of 293 subjects in the United States. The safety profile and effectiveness was found to be similar to the first test.
The substance is largely hyaluronic acid, a substance normally found in the skin, muscles, and tendons of mammals. Approved in June 2006 by the U.S. Food and Drug Administration, Juvéderm’s prime use is removing nasolabial folds, or “smile lines,” creases of skin which run from the corners of the nose to the corners of the mouth. It is also used as a lip augmentation agent, and to fill in hollow places and scars on the face. However, all hyaluronic acid facial filler products are eventually absorbed by the body, usually within six to nine months, causing the patient to undergo repeat injections to maintain the younger look. Juvéderm is also used by physicians to plump lips, which also lose fat and internal shape with normal aging.